Colistin Plus Rifampicin in MDR P. Aeruginosa and A. Baumanii
Condition(s):Drug SafetyLast Updated:January 2, 2012Unknown status
Hide Studies Not Open or Pending
Condition(s):Drug SafetyLast Updated:January 2, 2012Unknown status
Condition(s):Infection Due to Resistant Bacteria; Pneumonia, Ventilator-Associated; Hospital Acquired Pneumonia; Infection of Bloodstream; Infectious Disease of AbdomenLast Updated:April 16, 2012Completed
Condition(s):Treatment of Blood Stream Infections Due to Multidrug-Resistant Klebsiella PneumoniaeLast Updated:July 29, 2020Unknown status
Condition(s):Cross Infection; Pneumonia, BacterialLast Updated:August 6, 2009Unknown status
Condition(s):PneumoniaLast Updated:June 15, 2009Unknown status
Condition(s):Cystic FibrosisLast Updated:April 21, 2023Completed
Condition(s):Pneumonia, Ventilator-AssociatedLast Updated:February 17, 2016Completed
Condition(s):InfectionsLast Updated:May 22, 2006Unknown status
Condition(s):Acute Kidney Injury; Drug-Induced NephropathyLast Updated:October 31, 2023Recruiting
Condition(s):Cystic Fibrosis; Pseudomonas AeruginosaLast Updated:March 21, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.